Literature DB >> 2121336

Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation.

A L Kung1, A Zetterberg, S W Sherwood, R T Schimke.   

Abstract

Although agents which act in a cell cycle phase specific manner are commonly used in the clinic and in basic research, it is as yet unclear why these agents are cytotoxic. In this paper, we examine the cellular events associated with the cytotoxicity of aphidicolin and vincristine in CHO strain AA8 cells. Cell killing resulting from aphidicolin treatment was found to require a period of inhibition-free growth following removal of the drug and was associated with characteristic aberrant mitotic processes. The cytotoxic effects of aphidicolin could be antagonized by the concomitant inhibition of protein synthesis with cycloheximide in the period of DNA synthesis inhibition. Cell killing resulting from treatment with vincristine was associated with the aberrant segregation of nuclear material and the formation of multiple partial nuclei. Vincristine cytotoxicity was found to be antagonized by concomitant administration of cycloheximide or cytochalasin D. These data support a hypothesis that the cytotoxic effects of cell cycle phase specific agents do not derive directly from their biochemical actions per se. We propose that cell death results from processes that are evoked by dissociation of normally integrated cell cycle events, and that dissociation involves replicative/mitotic events in the case of aphidicolin and karyokinetic/nuclear reformation events in the case of vincristine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121336

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Cell death induced in L-cells by treatment with thymidine: staging of the process and relationship to apoptosis.

Authors:  J S Amenta; M J Sargus; F M Baccino; C Sacchi; G Bonelli
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-11       Impact factor: 2.416

3.  Activation of cyclin A-dependent protein kinases during apoptosis.

Authors:  W Meikrantz; S Gisselbrecht; S W Tam; R Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 4.  Programmed cell death--many questions still to be answered.

Authors:  C Binder; W Hiddemann
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

5.  Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation.

Authors:  X A Figueroa-Masot; M Hetman; M J Higgins; N Kokot; Z Xia
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

6.  Accumulation of HL-60 leukemia cells in G2/M and inhibition of cytokinesis caused by two marine compounds, bistratene A and cycloxazoline.

Authors:  D J Watters; H J Beamish; K A Marshall; R A Gardiner; G J Seymour; M F Lavin
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

8.  Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.

Authors:  C M Woods; J Zhu; P A McQueney; D Bollag; E Lazarides
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

Review 9.  Kinetic resistance to anticancer agents.

Authors:  M T Dimanche-Boitrel; C Garrido; B Chauffert
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 10.  DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis.

Authors:  Estelle Schmitt; Claudie Paquet; Myriam Beauchemin; Richard Bertrand
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.